Showing results (2061-2070 of 2,089) with videos related to

Sort By:
Pageof 209
Clinical Therapeutics|December 18, 2017
Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI StudyKi-Chul Sung, Yong-Seog Oh, Dong-Hun Cha, et al.
Clinical and Experimental Otorhinolaryngology|January 4, 2017
Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery, Soon-Hyun Ahn, Hyun Jun Hong, et al.
Nature|March 24, 2022
Metastable hexagonal close-packed palladium hydride in liquid cell TEMJaeyoung Hong, Jee-Hwan Bae, Hyesung Jo, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2020
Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemiaXuan Jin, Moo Hyun Kim, Ki Hoon Han, et al.
The International Journal of Cardiovascular Imaging|May 29, 2026
Optical coherence tomography-guided PCI in left anterior descending versus non-left anterior descending lesions: a prespecified substudy of the OCCUPI trialSoo-Jin Kim, Seung-Jun Lee, Sung-Jin Hong, et al.
JACC. Asia|November 7, 2022
Differential Long-Term Effects of First- and Second-Generation DES in Patients With Bifurcation Lesions Undergoing PCIKi Hong Choi, Young Bin Song, Joo Myung Lee, et al.
Circulation. Cardiovascular Interventions|February 19, 2020
Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting StentKi Hong Choi, Young Bin Song, Joo Myung Lee, et al.
Frontiers in Cardiovascular Medicine|January 9, 2023
Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patientsJung-Joon Cha, Soon Jun Hong, Ju Hyeon Kim, et al.
American Heart Journal|April 6, 2025
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROTECT- HBR trialJinho Lee, Han-Su Park, Junghoon Lee, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 27, 2022
Long-Term Clinical Outcomes and Its Predictors Between the 1- and 2-Stent Strategy in Coronary Bifurcation Lesions　- A Baseline Clinical and Lesion Characteristic-Matched AnalysisAlbert Youngwoo Jang, Minsu Kim, Pyung Chun Oh, et al.
Pageof 209